Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
- Martínez-Cuadrón, David
- Boluda, Blanca
- Martínez, Pilar
- Bergua, Juan
- Rodríguez-Veiga, Rebeca
- Esteve, Jordi
- Vives, Susana
- Serrano, Josefina
- Vidriales, Belen
- Salamero, Olga
- Cordón, Lourdes
- Sempere, Amparo
- Jiménez-Ubieto, Ana
- Prieto-Delgado, Julio
- Díaz-Beyá, Marina
- Garrido, Ana
- Benavente, Celina
- Pérez-Simón, José Antonio
- Moscardó, Federico
- Sanz, Miguel A
- Montesinos, Pau
- CETLAM and PETHEMA groups
DOIAbstract
The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández in the original article.The original version of this article was revised: The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández
Add to ORKG